Benjamin Hickey, EVP, Chief Commercial Officer at Mirati Therapeutics, Inc. (MRTX), sold 4,738 shares at $177.71 ($836K) on 2021-03-19, disclosed to the SEC on 2021-03-22.
Open-market sale of $836k MRTX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.54 | 588 | $103K | 12.3% |
| 2 | $175.54 | 588 | $103K | 12.3% |
| 3 | $176.42 | 1,350 | $238K | 28.5% |
| 4 | $176.42 | 1,350 | $238K | 28.5% |
| 5 | $177.71 | 431 | $77K | 9.2% |
| 6 | $177.71 | 431 |
| $77K |
| 9.2% |
| Total | $176.44 avg | 4,738 | $836K | 100% |
| Filing → |
| MRTX | SELL | 2024-01-09 | $246K | — | Filing → |
| MRTX | SELL | 2023-12-14 | $252K | — | Filing → |
| MRTX | SELL | 2023-01-19 | $66K | — | Filing → |